A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Adaptive Biotechnologies Corp stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 5,334 shares of ADPT stock, worth $23,309. This represents 0.0% of its overall portfolio holdings.

Number of Shares
5,334
Previous 4,400 21.23%
Holding current value
$23,309
Previous $15,000 80.0%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024

BUY
$3.37 - $5.12 $3,147 - $4,782
934 Added 21.23%
5,334 $27,000
Q2 2024

Jul 30, 2024

SELL
$2.34 - $3.96 $107,824 - $182,472
-46,079 Reduced 91.28%
4,400 $15,000
Q1 2024

May 01, 2024

SELL
$2.88 - $4.8 $11,324 - $18,873
-3,932 Reduced 7.23%
50,479 $162,000
Q4 2023

Jan 24, 2024

BUY
$3.46 - $5.33 $750 - $1,156
217 Added 0.4%
54,411 $266,000
Q3 2023

Oct 26, 2023

SELL
$5.07 - $8.44 $5,577 - $9,284
-1,100 Reduced 1.99%
54,194 $295,000
Q2 2023

Aug 10, 2023

SELL
$6.19 - $8.78 $7,477 - $10,606
-1,208 Reduced 2.14%
55,294 $371,000
Q1 2023

May 04, 2023

SELL
$7.8 - $10.11 $15,857 - $20,553
-2,033 Reduced 3.47%
56,502 $498,000
Q4 2022

Feb 09, 2023

BUY
$6.26 - $9.34 $10,679 - $15,934
1,706 Added 3.0%
58,535 $447,000
Q3 2022

Nov 10, 2022

BUY
$6.5 - $12.67 $107,250 - $209,055
16,500 Added 40.91%
56,829 $404,000
Q2 2022

Jul 26, 2022

BUY
$6.4 - $14.73 $258,105 - $594,046
40,329 New
40,329 $326,000
Q4 2019

Feb 12, 2020

SELL
$24.56 - $32.8 $4.12 Million - $5.5 Million
-167,600 Closed
0 $0
Q3 2019

Nov 12, 2019

BUY
$30.31 - $53.51 $5.08 Million - $8.97 Million
167,600 New
167,600 $5.18 Million

Others Institutions Holding ADPT

About Adaptive Biotechnologies Corp


  • Ticker ADPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 142,872,992
  • Market Cap $624M
  • Description
  • Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...
More about ADPT
Track This Portfolio

Track Mirae Asset Global Investments Co., Ltd. Portfolio

Follow Mirae Asset Global Investments Co., Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirae Asset Global Investments Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mirae Asset Global Investments Co., Ltd. with notifications on news.